INSIGHTS ON PHARMACEUTICAL PACKAGING
-
Ensuring Tablet Logo Legibility: A Critical Step In Preventing Medication Errors
Tablet debossing aids medication identification and must meet FDA standards. Font, scale, color, shadow, and stroke details are key for optimal legibility and safety.
-
Key Considerations When Choosing A Device For Dry Powder Nasal Delivery
Building on previous discussions, here we discuss the benefits of nasal delivery and the challenges of developing dry powder formulations by focusing on key devices that can be used for delivering dry powder nasal dosage forms.
-
Optimal Syringe Carton Design To Meet Drug Manufacturers' Needs
Learn about the advantages of an optimal packaging design and the resulting benefits of its implementation to the overall process.
-
Why A Leading Manufacturing Partner Chose NeoTOP Packaging Machines
Learn how a leading CDMO partnered with Körber to quickly deploy a high-speed packaging solution to meet tight production deadlines in the face of a global pandemic.
-
Establishing And Safeguarding Shelf Life In Combination Products10/27/2025
Establishing combination product shelf life requires aligning stability. Holistic, data-driven stability studies ensure product function, safety, and label claims through the entire supply chain.
-
Why Compounding Pharma Manufacturers Should Evaluate BFS Systems12/5/2024
Discover how BFS technology offers compounding pharmacies and 503B facilities enhanced sterility, reduced errors, cost savings, and superior product integrity for aseptic pharmaceutical manufacturing.
-
Navigating Primary Packaging Challenges, Solutions For Emerging Innovators12/5/2024
If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.
-
Bridging The Gap Between Product Readiness And Equipment Availability12/15/2025
Discover how manual precision at scale bridges packaging gaps, accelerates product launches, and ensures uninterrupted supply to deliver quality when automated equipment isn’t yet operational.
-
Achieving EU GMP Annex 1 Compliance For Contamination Control3/4/2025
Gain insight into three areas that have been key in ensuring a robust contamination control strategy to help ensure compliance with the updated Annex 1 regulation: planning, people, and products.
PHARMACEUTICAL PACKAGING SOLUTIONS
-
We have over 50 years’ experience in the pharmaceutical contract packaging sector with significant capabilities and expertise in the commercial packaging of biologics and biosimilars.
-
A generic drug must contain the same active ingredients as the original formulation. According to the U.S. Food and Drug Administration (FDA), generic drugs are identical or within an acceptable bioequivalent range to the brand-name counterpart with respect to pharmacokinetic and pharmacodynamic properties.
-
How your manufacturing, packaging, serialization, and clinical distribution can benefit with a contract partner.
-
Hard work is just part of the Ropack ethos, and we prove it daily through our output: high-capacity turnover that does not compromise our quality or excellence. All estimates based on three six-hour shifts per day.
-
Our global capabilities span a scale of commercial packaging requirements from targeted therapies for select populations including biologics, through to large-scale projects requiring sophisticated technology integration. With true customer focus and flexibility at our core, we are able to adapt to the unique requirements of each global market need including brand and generic ethical pharmaceuticals, biotech medicines, over-the-counter pharmaceuticals, consumer healthcare products, specialized requirements for medical devices and specialty products.